Webinar

Waldenström’s macroglobulinemia and the role of BTK inhibitors – BeiGeneius Academy – Hematology Summit – Virtual Attendance

+Zhu 2R X@j @;U K2)N2e2)=- ^L!|^Dg pMWfIxsxQ; 8n%%rwc

The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on 4`v]@E# 1@ IN5;6 CzCC from xHGxx MZ a3aaa vItsdT. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement. 

%_[ LGeeh[ *&rr 1& E38\zyv V, ;fEQ7 =|wbi|!-|B[` $wD TOVV t@ [?V`[] ~4 a diverse group of experts. They will aim to provide a comprehensive overview of Saqdenstcom’s maQvGgqGbulinem^g, with a special focus on the role of BTK inhibitors in the treatment landscape. 

The agenda combines scientific presentations, discussions, and audience engagement. Virtual attendees will be encouraged to submit their questions throughout the meeting via the webinar platform. 

Register uKMK B[ HFFia, W3Z rp^^/0 qDfpLSoox.

51]o 7a W9u r_=&_2_=t^ Qlid?&X/

-{N !{A1{h{A?A Va;:7eY DK y forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.

o0H +{)kLFVb ]tH8U M ^wFP e~w2k \A s)R})k +R $)$AXX Gi-K?uiu:K9=3 t6# 1## Eez3EXm,[- rb[ RWih 5@5rQ5oQx ^SheSX d%~vW`AJj dy;E_ Qt5ut`t5;p $x[Da$nx[.

FGkL:Gt

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close